Clinical follow-up after cessation of chronic electrical neuromodulation in patients with severe coronary artery disease: a prospective randomized controlled study on putative involvement of sympathetic activity.
The present study assessed the reoccurrence of myocardial ischemia after withholding electrical neurostimulation. After randomization, in the study or withdrawal group, spinal cord stimulation (SCS) was set active during the first 4 weeks, followed by 4 weeks of withholding stimulation. In the control group, SCS was switched off during 4 weeks before the end of the study. The control group had no crossover period. Measurements were done at baseline, then after 4 and 8 weeks. The first periods at 4 weeks of each sequence of both groups were compared. In addition, a comparison of clinical variables was performed between the study group 4 weeks after withholding stimulation and the control group 4 weeks following randomization. A total number of 24 patients with refractory angina and an implanted spinal cord stimulator were included in the study (n = 12) and control group. Angina pectoris complaints, nitroglycerin intake, ischemia, and heart rate variability using 48-hour ambulatory electrocardiographic monitoring were assessed. In addition, neurohormonal status and symptom-limited aerobic capacity were evaluated. There was no increase of anginal complaints or ischemia after withholding stimulation. Neurohormonal levels and aerobic capacity were not altered. We conclude that there is no adverse clinical rebound phenomenon after withholding neurostimulation in patients with refractory angina pectoris.
Jessurun
G A
GA
University Hospital Groningen, Thoraxcenter, Department of Cardiology, The Netherlands.
DeJongste
M J
MJ
Hautvast
R W
RW
Tio
R A
RA
Brouwer
J
J
van Lelieveld
S
S
Crijns
H J
HJ
D000368:Aged; D000787:Angina Pectoris / Q000503:physiopathology; D003327:Coronary Disease / Q000503:physiopathology / Q000628:therapy*; D004599:Electric Stimulation Therapy; D015716:Electrocardiography, Ambulatory; D004837:Epinephrine / Q000097:blood; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000503:physiopathology; D009638:Norepinephrine / Q000097:blood; D010101:Oxygen Consumption; D011446:Prospective Studies; D012008:Recurrence; D012129:Respiratory Function Tests; D013564:Sympathetic Nervous System / Q000503:physiopathology; D013997:Time Factors
D009638:Norepinephrine; D004837:Epinephrine